Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Porewater dynamics of silver, lead and copper in coastal sediments and implications for benthic metal fluxes.

The Science of the total environment·2015
Same author

Semiochemicals for use with parasitoids: Status and future.

Journal of chemical ecology·2013
Same author

Response of parasitoidEucelatoria bryani to selected plant material in an olfactometer.

Journal of chemical ecology·2013
Same author

Reproduction in grazing dairy cows treated with 14-day controlled internal drug release for presynchronization before timed artificial insemination compared with artificial insemination after observed estrus.

Journal of dairy science·2012
Same author

Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype.

Diabetologia·2012
Same author

Short communication: presynchronization for timed artificial insemination in grazing dairy cows by using progesterone for 14 days with or without prostaglandin F2α at the time of progesterone withdrawal.

Journal of dairy science·2012
Same journal

Correction to I.M. Matters News: Sleep medicine for seniors.

Annals of internal medicine·2026
Same journal

Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.

Annals of internal medicine·2026
Same journal

Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026
Same journal

Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes : A Phase 2b Randomized Clinical Trial.

Annals of internal medicine·2026
Same journal

Grappling with GLP-1 prescribing.

Annals of internal medicine·2026
See all related articles

Related Experiment Video

Updated: May 7, 2026

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Naloxone.

W R Martin

    Annals of Internal Medicine
    |December 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Naloxone, a narcotic antagonist, reverses the effects of opioid agonists by blocking receptor binding. It is crucial for treating overdoses and has potential in various unapproved clinical applications.

    More Related Videos

    Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
    10:13

    Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

    Published on: November 8, 2024

    Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
    13:18

    Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

    Published on: November 22, 2024

    Related Experiment Videos

    Last Updated: May 7, 2026

    Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
    10:13

    Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

    Published on: June 9, 2017

    Fentanyl Analog Screening using LC-TIMS-TOF MS/MS
    10:13

    Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

    Published on: November 8, 2024

    Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
    13:18

    Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion

    Published on: November 22, 2024

    Area of Science:

    • Pharmacology
    • Neuroscience

    Background:

    • Narcotic analgesics activate receptors affecting pain, mood, and respiration.
    • Naloxone is the first identified antagonist with no agonistic properties.

    Purpose of the Study:

    • To describe the mechanism of action and applications of naloxone.
    • To outline the clinical use of naloxone in various scenarios.

    Main Methods:

    • Review of naloxone's competitive antagonism at multiple receptors.
    • Analysis of naloxone's role in displacing agonist binding.

    Main Results:

    • Naloxone competitively antagonizes narcotic binding, reversing their effects.
    • Naloxone corrects narcotic-induced homeostatic depression and precipitates withdrawal.

    Conclusions:

    • Naloxone is essential for managing narcotic overdose and surgical analgesia reversal.
    • Naloxone has potential in treating overdose, neonatal cases, and unapproved uses like reversing psychotomimetic effects.